Literature DB >> 18855353

Association between serum C-reactive protein elevation and atrial fibrillation after first anterior myocardial infarction.

Omer Gedikli1, Cihan Orem, Merih Baykan, Caner Karahan, Mehmet Kucukosmanoglu, Sinan Sahin, Levent Korkmaz, Hulya Yilmaz, Sukru Celik.   

Abstract

BACKGROUND: Elevated inflammatory markers have been found to correlate with higher risk for cardiac events in patients with acute myocardial infarction (AMI). It has been suggested that C-reactive protein (CRP) may be involved in the initiation process of atrial fibrillation (AF). However, the role of CRP levels in the occurence of AF in patients with AMI has not been studied. This study investigated whether CRP is a risk factor for AF in patients with acute anterior MI.
METHODS: We prospectively evaluated 92 consecutive patients (25 women and 67 men; aged 58 +/- 11 y) with a first acute anterior wall MI. Blood samples were obtained at the time of admission to the hospital, and serum CRP levels were measured by an ultrasensitive immunonephelometry method. All patients were evaluated by echocardiography to measure the left ventricular (LV) diameter and functions. All patients were monitored continuously for the detection of AF in the coronary care unit.
RESULTS: Atrial fibrillation occured in 19 (20%) of 92 patients. Univariate analysis showed that patients with AF had an advanced age (63 +/- 9.9 versus 56.7 +/- 11.7 y, p = 0.034), higher serum CRP level (2.95 +/- 2.5 versus 1.71 +/- 2.12 mg/dL, p = 0.034), larger LV end-systolic volume (74 +/- 15 versus 63 +/- 19, mL p = 0.02), higher LV ejection fraction (31.1 +/- 6.2 versus 38.4 +/- 10%, p = 0.001), and larger left atrial (LA) diameter (37.1 +/- 4.2 versus 34.7 +/- 3.3 mm, p = 0.01). In multivariate analysis, only age (odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1-1.11, p = 0.036) and CRP levels (OR: 1.27, 95% CI: 1-1.59, p = 0.039) were independent predictors of AF.
CONCLUSION: These results suggest that CRP may be a risk factor for AF in patients with acute anterior wall MI. Copyright (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855353      PMCID: PMC6653053          DOI: 10.1002/clc.20276

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  C-Reactive Protein and The Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Venkata M Alla; Senthil Thambidorai; Kishlay Anand; Aryan N Mooss; Richard Baltaro; Syed M Mohiuddin
Journal:  J Atr Fibrillation       Date:  2010-01-01

2.  New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).

Authors:  Susmita Parashar; Danesh Kella; Kimberly J Reid; John A Spertus; Fengming Tang; Jonathan Langberg; Viola Vaccarino; Michael C Kontos; Renato D Lopes; Michael S Lloyd
Journal:  Am J Cardiol       Date:  2013-11-01       Impact factor: 2.778

3.  Clinical risk factors for new-onset atrial fibrillation in acute myocardial infarction: A systematic review and meta-analysis.

Authors:  Jing He; Yi Yang; Gui Zhang; Xiu-Hong Lu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Postoperative atrial fibrillation may be associated with other factors.

Authors:  Ali Rıza Akyüz; Levent Korkmaz
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

5.  Left ventricular ejection fraction and left atrium diameter related to new-onset atrial fibrillation following acute myocardial infarction: a systematic review and meta-analysis.

Authors:  Rui-Xiang Zeng; Mao-Sheng Chen; Bao-Tao Lian; Peng-Da Liao; Min-Zhou Zhang
Journal:  Oncotarget       Date:  2017-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.